Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:29 pm
| PEG Ratio | 12.83 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Dalmia Bharat Ltd, operating in the cement industry, reported a current price of ₹2,128 and a market capitalization of ₹39,914 Cr. The company has shown a consistent upward trajectory in revenue, with sales rising from ₹11,286 Cr in FY 2022 to ₹13,552 Cr in FY 2023, and further to ₹14,691 Cr in FY 2024. However, the trailing twelve months (TTM) revenue stood slightly lower at ₹13,995 Cr. This indicates a slight decline in revenue generation compared to the previous fiscal year. Quarterly sales have fluctuated, with the highest recorded in March 2024 at ₹4,307 Cr, while the lowest was in September 2022 at ₹2,971 Cr. The company’s ability to maintain a reasonable sales volume amidst these fluctuations underscores its resilience in a challenging market environment, particularly given the recent pressures faced by the cement sector due to rising input costs and competition.
Profitability and Efficiency Metrics
Dalmia Bharat’s profitability metrics reflect a mixed performance. The net profit for FY 2023 stood at ₹1,079 Cr, which subsequently declined to ₹853 Cr in FY 2024 and is projected at ₹699 Cr for FY 2025. The operating profit margin (OPM) was recorded at 17% in FY 2023 and is expected to remain stable around 17% in FY 2025. The return on equity (ROE) was reported at 4.15%, which indicates a relatively low return compared to industry standards. The company’s interest coverage ratio (ICR) stood at 6.67x, suggesting a strong ability to meet interest obligations. However, the cash conversion cycle (CCC) at -1 days reflects efficient management of working capital. While the OPM and ICR indicate operational stability, the declining net profit raises concerns regarding long-term profitability and cost management strategies.
Balance Sheet Strength and Financial Ratios
Dalmia Bharat’s balance sheet reveals a total debt of ₹5,702 Cr against reserves of ₹17,336 Cr, indicating a debt-to-equity ratio of 0.30, which is relatively low and implies financial stability. The company reported an asset turnover ratio of 0.48, indicating moderate efficiency in utilizing assets to generate revenue. The current ratio stood at 1.59, suggesting adequate liquidity to cover short-term liabilities. Additionally, the interest coverage ratio of 6.67x signifies that the company can comfortably meet its interest expenses. However, the return on capital employed (ROCE) was only 5.58%, indicating that the capital is not being utilized efficiently to generate returns. This inefficiency, combined with a low net profit margin of 5.00%, suggests a need for improved operational efficiency and cost control measures to enhance profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Dalmia Bharat reflects a significant promoter holding of 55.84%, which indicates strong control and commitment from the founding family. Foreign Institutional Investors (FIIs) hold 8.75%, while Domestic Institutional Investors (DIIs) constitute 17.81% of the total equity, demonstrating a balanced institutional interest. The public shareholding stood at 17.45%, down from 23.45% in December 2022. The number of shareholders increased to 75,971, indicating growing retail interest despite the decline in public shareholding percentage. This shift may suggest a consolidation of shares among institutional investors and promoters, which can be interpreted as a vote of confidence in the company’s long-term prospects. However, the declining public shareholding may raise concerns about liquidity and market participation from retail investors.
Outlook, Risks, and Final Insight
Looking ahead, Dalmia Bharat faces both opportunities and challenges. The company’s strong market position and consistent revenue generation provide a solid foundation for future growth. However, the declining profitability metrics, particularly the net profit and ROE, pose risks that could hinder long-term performance. Additionally, the cement industry is sensitive to fluctuations in raw material prices and infrastructure spending, which could impact margins. While the company’s efficient working capital management and low debt levels present strengths, it must focus on enhancing operational efficiency to improve profitability. The outlook remains cautiously optimistic, contingent upon the company’s ability to navigate these challenges and capitalize on growth opportunities in the expanding infrastructure sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Dalmia Bharat Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 24.0/16.2 | 3.95 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,52,148 Cr. | 11,950 | 13,102/10,048 | 48.0 | 2,444 | 0.65 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 24,262 Cr. | 1,026 | 1,209/788 | 168 | 317 | 0.20 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 12,444 Cr. | 402 | 430/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 10,505 Cr. | 260 | 309/172 | 44.4 | 71.2 | 0.38 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 36,141.39 Cr | 2,000.77 | 42.12 | 568.41 | 0.50% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,302 | 2,971 | 3,355 | 3,915 | 3,627 | 3,153 | 3,604 | 4,307 | 3,621 | 3,087 | 3,181 | 4,091 | 3,636 |
| Expenses | 2,713 | 2,592 | 2,711 | 3,205 | 3,014 | 2,560 | 2,825 | 3,653 | 2,952 | 2,653 | 2,670 | 3,298 | 2,753 |
| Operating Profit | 589 | 379 | 644 | 710 | 613 | 593 | 779 | 654 | 669 | 434 | 511 | 793 | 883 |
| OPM % | 18% | 13% | 19% | 18% | 17% | 19% | 22% | 15% | 18% | 14% | 16% | 19% | 24% |
| Other Income | 39 | 33 | 42 | 424 | 54 | 80 | 60 | 120 | -63 | 73 | 37 | 93 | 65 |
| Interest | 47 | 54 | 69 | 64 | 83 | 101 | 108 | 94 | 95 | 98 | 101 | 105 | 108 |
| Depreciation | 312 | 332 | 325 | 336 | 399 | 401 | 370 | 328 | 317 | 336 | 364 | 314 | 322 |
| Profit before tax | 269 | 26 | 292 | 734 | 185 | 171 | 361 | 352 | 194 | 73 | 83 | 467 | 518 |
| Tax % | 24% | -81% | 25% | 17% | 22% | 28% | 26% | 9% | 25% | 33% | 20% | 6% | 24% |
| Net Profit | 205 | 47 | 218 | 609 | 144 | 123 | 266 | 320 | 145 | 49 | 66 | 439 | 395 |
| EPS in Rs | 10.46 | 2.45 | 10.88 | 31.42 | 6.93 | 6.29 | 14.02 | 16.80 | 7.52 | 2.45 | 3.25 | 23.19 | 20.95 |
Last Updated: August 1, 2025, 10:20 pm
Below is a detailed analysis of the quarterly data for Dalmia Bharat Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3,636.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,091.00 Cr. (Mar 2025) to 3,636.00 Cr., marking a decrease of 455.00 Cr..
- For Expenses, as of Jun 2025, the value is 2,753.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,298.00 Cr. (Mar 2025) to 2,753.00 Cr., marking a decrease of 545.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 883.00 Cr.. The value appears strong and on an upward trend. It has increased from 793.00 Cr. (Mar 2025) to 883.00 Cr., marking an increase of 90.00 Cr..
- For OPM %, as of Jun 2025, the value is 24.00%. The value appears strong and on an upward trend. It has increased from 19.00% (Mar 2025) to 24.00%, marking an increase of 5.00%.
- For Other Income, as of Jun 2025, the value is 65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 93.00 Cr. (Mar 2025) to 65.00 Cr., marking a decrease of 28.00 Cr..
- For Interest, as of Jun 2025, the value is 108.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 105.00 Cr. (Mar 2025) to 108.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 322.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 314.00 Cr. (Mar 2025) to 322.00 Cr., marking an increase of 8.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 518.00 Cr.. The value appears strong and on an upward trend. It has increased from 467.00 Cr. (Mar 2025) to 518.00 Cr., marking an increase of 51.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 6.00% (Mar 2025) to 24.00%, marking an increase of 18.00%.
- For Net Profit, as of Jun 2025, the value is 395.00 Cr.. The value appears to be declining and may need further review. It has decreased from 439.00 Cr. (Mar 2025) to 395.00 Cr., marking a decrease of 44.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 20.95. The value appears to be declining and may need further review. It has decreased from 23.19 (Mar 2025) to 20.95, marking a decrease of 2.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:28 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,444 | 8,579 | 9,484 | 9,674 | 10,110 | 11,286 | 13,552 | 14,691 | 13,980 | 13,995 |
| Expenses | 5,550 | 6,543 | 7,542 | 7,591 | 7,340 | 8,860 | 11,224 | 12,052 | 11,573 | 11,374 |
| Operating Profit | 1,894 | 2,036 | 1,942 | 2,083 | 2,770 | 2,426 | 2,328 | 2,639 | 2,407 | 2,621 |
| OPM % | 25% | 24% | 20% | 22% | 27% | 22% | 17% | 18% | 17% | 19% |
| Other Income | 296 | 274 | 235 | 217 | 145 | 171 | 532 | 314 | 140 | 268 |
| Interest | 856 | 708 | 542 | 415 | 303 | 202 | 234 | 386 | 399 | 412 |
| Depreciation | 1,226 | 1,213 | 1,296 | 1,528 | 1,250 | 1,235 | 1,305 | 1,498 | 1,331 | 1,336 |
| Profit before tax | 108 | 389 | 339 | 357 | 1,362 | 1,160 | 1,321 | 1,069 | 817 | 1,141 |
| Tax % | 69% | 25% | -3% | 33% | 13% | 27% | 18% | 20% | 14% | |
| Net Profit | 44 | 291 | 349 | 238 | 1,183 | 845 | 1,079 | 853 | 699 | 949 |
| EPS in Rs | 8,800.00 | 58,400.00 | 15.96 | 11.61 | 62.58 | 43.55 | 55.21 | 44.04 | 36.41 | 49.84 |
| Dividend Payout % | 0% | 1,937% | 13% | 17% | 2% | 20% | 16% | 21% | 25% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 561.36% | 19.93% | -31.81% | 397.06% | -28.57% | 27.69% | -20.95% | -18.05% |
| Change in YoY Net Profit Growth (%) | 0.00% | -541.43% | -51.74% | 428.86% | -425.63% | 56.26% | -48.64% | 2.89% |
Dalmia Bharat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 7% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | -2% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 26% |
| 3 Years: | 16% |
| 1 Year: | 25% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 2:35 am
Balance Sheet
Last Updated: July 25, 2025, 3:22 pm
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6,654 | 6,654 | 39 | 39 | 37 | 37 | 37 | 38 | 38 |
| Reserves | 2,975 | 3,681 | 10,600 | 10,522 | 12,773 | 16,024 | 15,591 | 16,359 | 17,336 |
| Borrowings | 8,038 | 7,266 | 5,883 | 6,049 | 3,839 | 3,176 | 3,855 | 4,805 | 5,702 |
| Other Liabilities | 3,595 | 3,763 | 4,016 | 4,268 | 5,237 | 5,431 | 6,036 | 6,510 | 7,095 |
| Total Liabilities | 21,262 | 21,364 | 20,538 | 20,878 | 21,886 | 24,668 | 25,519 | 27,712 | 30,171 |
| Fixed Assets | 15,516 | 14,037 | 13,573 | 12,555 | 13,626 | 14,147 | 14,784 | 15,732 | 17,306 |
| CWIP | 128 | 168 | 520 | 1,740 | 1,006 | 1,034 | 1,871 | 2,395 | 2,616 |
| Investments | 2,740 | 3,505 | 2,424 | 2,816 | 4,033 | 5,704 | 3,524 | 4,462 | 5,119 |
| Other Assets | 2,878 | 3,654 | 4,021 | 3,767 | 3,221 | 3,783 | 5,340 | 5,123 | 5,130 |
| Total Assets | 21,262 | 21,364 | 20,538 | 20,878 | 21,886 | 24,668 | 25,519 | 27,712 | 30,171 |
Below is a detailed analysis of the balance sheet data for Dalmia Bharat Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 38.00 Cr..
- For Reserves, as of Mar 2025, the value is 17,336.00 Cr.. The value appears strong and on an upward trend. It has increased from 16,359.00 Cr. (Mar 2024) to 17,336.00 Cr., marking an increase of 977.00 Cr..
- For Borrowings, as of Mar 2025, the value is 5,702.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4,805.00 Cr. (Mar 2024) to 5,702.00 Cr., marking an increase of 897.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7,095.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,510.00 Cr. (Mar 2024) to 7,095.00 Cr., marking an increase of 585.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 30,171.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27,712.00 Cr. (Mar 2024) to 30,171.00 Cr., marking an increase of 2,459.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 17,306.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,732.00 Cr. (Mar 2024) to 17,306.00 Cr., marking an increase of 1,574.00 Cr..
- For CWIP, as of Mar 2025, the value is 2,616.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,395.00 Cr. (Mar 2024) to 2,616.00 Cr., marking an increase of 221.00 Cr..
- For Investments, as of Mar 2025, the value is 5,119.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,462.00 Cr. (Mar 2024) to 5,119.00 Cr., marking an increase of 657.00 Cr..
- For Other Assets, as of Mar 2025, the value is 5,130.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,123.00 Cr. (Mar 2024) to 5,130.00 Cr., marking an increase of 7.00 Cr..
- For Total Assets, as of Mar 2025, the value is 30,171.00 Cr.. The value appears strong and on an upward trend. It has increased from 27,712.00 Cr. (Mar 2024) to 30,171.00 Cr., marking an increase of 2,459.00 Cr..
Notably, the Reserves (17,336.00 Cr.) exceed the Borrowings (5,702.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | -5.00 | -4.00 | -4.00 | -1.00 | -1.00 | -1.00 | -2.00 | -3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 24 | 21 | 25 | 18 | 22 | 19 | 21 | 23 |
| Inventory Days | 189 | 186 | 211 | 204 | 180 | 234 | 242 | 164 | 217 |
| Days Payable | 258 | 223 | 179 | 173 | 213 | 211 | 209 | 178 | 241 |
| Cash Conversion Cycle | -43 | -13 | 53 | 55 | -14 | 45 | 52 | 8 | -1 |
| Working Capital Days | -89 | -63 | -60 | -85 | -83 | -60 | -33 | -27 | -39 |
| ROCE % | 6% | 4% | 4% | 10% | 7% | 8% | 7% | 6% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Growth Fund | 1,635,069 | 1.8 | 344.06 | 1,635,069 | 2025-04-22 17:25:37 | 0% |
| Sundaram Mid Cap Fund | 897,062 | 2.46 | 215.69 | 897,062 | 2025-04-22 17:25:37 | 0% |
| Sundaram Mid Cap Fund - Institutional Plan | 897,062 | 2.46 | 215.69 | 897,062 | 2025-04-22 17:25:37 | 0% |
| ICICI Prudential MidCap Fund | 507,962 | 2.78 | 122.13 | 507,962 | 2025-04-22 17:25:37 | 0% |
| HSBC Midcap Fund | 426,432 | 1.12 | 89.73 | 426,432 | 2025-04-22 17:25:37 | 0% |
| Sundaram Large and Mid Cap Fund | 250,000 | 1.09 | 60.11 | 250,000 | 2025-04-22 17:25:37 | 0% |
| UTI Nifty200 Momentum 30 Index Fund | 212,606 | 1.93 | 51.12 | 212,606 | 2025-04-22 17:25:37 | 0% |
| UTI Large & Mid Cap Fund | 206,177 | 2.48 | 49.57 | 206,177 | 2025-04-22 17:25:37 | 0% |
| Invesco India Arbitrage Fund | 219,500 | 0.53 | 46.19 | 219,500 | 2025-04-22 17:25:37 | 0% |
| ICICI Prudential Commodities Fund | 182,381 | 3.31 | 43.85 | 182,381 | 2025-04-22 17:25:37 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 36.42 | 44.05 | 55.22 | 61.84 | 65.65 |
| Diluted EPS (Rs.) | 36.42 | 44.03 | 55.19 | 61.84 | 65.55 |
| Cash EPS (Rs.) | 106.84 | 123.74 | 98.92 | 129.95 | 135.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 914.42 | 868.79 | 851.03 | 851.84 | 684.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 914.42 | 868.79 | 851.03 | 851.84 | 684.49 |
| Revenue From Operations / Share (Rs.) | 735.79 | 773.21 | 731.89 | 610.05 | 568.76 |
| PBDIT / Share (Rs.) | 140.00 | 155.47 | 132.65 | 139.78 | 160.70 |
| PBIT / Share (Rs.) | 69.95 | 76.63 | 62.11 | 72.97 | 92.49 |
| PBT / Share (Rs.) | 43.00 | 56.32 | 41.68 | 61.95 | 76.11 |
| Net Profit / Share (Rs.) | 36.79 | 44.89 | 28.38 | 63.13 | 67.19 |
| NP After MI And SOA / Share (Rs.) | 35.95 | 43.47 | 55.95 | 61.84 | 66.54 |
| PBDIT Margin (%) | 19.02 | 20.10 | 18.12 | 22.91 | 28.25 |
| PBIT Margin (%) | 9.50 | 9.91 | 8.48 | 11.96 | 16.26 |
| PBT Margin (%) | 5.84 | 7.28 | 5.69 | 10.15 | 13.38 |
| Net Profit Margin (%) | 5.00 | 5.80 | 3.87 | 10.34 | 11.81 |
| NP After MI And SOA Margin (%) | 4.88 | 5.62 | 7.64 | 10.13 | 11.69 |
| Return on Networth / Equity (%) | 3.93 | 5.03 | 6.62 | 7.29 | 9.74 |
| Return on Capital Employeed (%) | 5.31 | 6.25 | 5.44 | 6.71 | 10.15 |
| Return On Assets (%) | 2.25 | 2.97 | 4.05 | 4.59 | 5.64 |
| Long Term Debt / Equity (X) | 0.26 | 0.27 | 0.20 | 0.12 | 0.16 |
| Total Debt / Equity (X) | 0.30 | 0.28 | 0.23 | 0.19 | 0.23 |
| Asset Turnover Ratio (%) | 0.48 | 0.55 | 0.53 | 0.01 | 0.01 |
| Current Ratio (X) | 1.59 | 1.76 | 1.65 | 1.57 | 1.31 |
| Quick Ratio (X) | 1.33 | 1.48 | 1.35 | 1.38 | 1.12 |
| Inventory Turnover Ratio (X) | 3.95 | 4.13 | 4.94 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 24.74 | 20.46 | 16.32 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 8.39 | 7.27 | 7.22 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 75.26 | 79.54 | 83.68 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 91.61 | 92.73 | 92.78 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 6.67 | 7.65 | 10.49 | 12.80 | 9.81 |
| Interest Coverage Ratio (Post Tax) (X) | 3.04 | 3.21 | 3.88 | 6.75 | 5.10 |
| Enterprise Value (Cr.) | 39795.55 | 41059.80 | 39904.23 | 30682.95 | 32013.43 |
| EV / Net Operating Revenue (X) | 2.85 | 2.79 | 2.95 | 2.72 | 3.04 |
| EV / EBITDA (X) | 14.96 | 13.90 | 16.26 | 11.87 | 10.77 |
| MarketCap / Net Operating Revenue (X) | 2.47 | 2.51 | 2.68 | 2.45 | 2.79 |
| Retention Ratios (%) | 75.25 | 79.53 | 83.67 | 0.00 | 0.00 |
| Price / BV (X) | 1.99 | 2.25 | 2.32 | 1.76 | 2.33 |
| Price / Net Operating Revenue (X) | 2.47 | 2.51 | 2.68 | 2.45 | 2.79 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.04 | 0.04 |
After reviewing the key financial ratios for Dalmia Bharat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 36.42. This value is within the healthy range. It has decreased from 44.05 (Mar 24) to 36.42, marking a decrease of 7.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 36.42. This value is within the healthy range. It has decreased from 44.03 (Mar 24) to 36.42, marking a decrease of 7.61.
- For Cash EPS (Rs.), as of Mar 25, the value is 106.84. This value is within the healthy range. It has decreased from 123.74 (Mar 24) to 106.84, marking a decrease of 16.90.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 914.42. It has increased from 868.79 (Mar 24) to 914.42, marking an increase of 45.63.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 914.42. It has increased from 868.79 (Mar 24) to 914.42, marking an increase of 45.63.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 735.79. It has decreased from 773.21 (Mar 24) to 735.79, marking a decrease of 37.42.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 140.00. This value is within the healthy range. It has decreased from 155.47 (Mar 24) to 140.00, marking a decrease of 15.47.
- For PBIT / Share (Rs.), as of Mar 25, the value is 69.95. This value is within the healthy range. It has decreased from 76.63 (Mar 24) to 69.95, marking a decrease of 6.68.
- For PBT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has decreased from 56.32 (Mar 24) to 43.00, marking a decrease of 13.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 36.79. This value is within the healthy range. It has decreased from 44.89 (Mar 24) to 36.79, marking a decrease of 8.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 35.95. This value is within the healthy range. It has decreased from 43.47 (Mar 24) to 35.95, marking a decrease of 7.52.
- For PBDIT Margin (%), as of Mar 25, the value is 19.02. This value is within the healthy range. It has decreased from 20.10 (Mar 24) to 19.02, marking a decrease of 1.08.
- For PBIT Margin (%), as of Mar 25, the value is 9.50. This value is below the healthy minimum of 10. It has decreased from 9.91 (Mar 24) to 9.50, marking a decrease of 0.41.
- For PBT Margin (%), as of Mar 25, the value is 5.84. This value is below the healthy minimum of 10. It has decreased from 7.28 (Mar 24) to 5.84, marking a decrease of 1.44.
- For Net Profit Margin (%), as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 5.80 (Mar 24) to 5.00, marking a decrease of 0.80.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 8. It has decreased from 5.62 (Mar 24) to 4.88, marking a decrease of 0.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.93. This value is below the healthy minimum of 15. It has decreased from 5.03 (Mar 24) to 3.93, marking a decrease of 1.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.31. This value is below the healthy minimum of 10. It has decreased from 6.25 (Mar 24) to 5.31, marking a decrease of 0.94.
- For Return On Assets (%), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 5. It has decreased from 2.97 (Mar 24) to 2.25, marking a decrease of 0.72.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has decreased from 0.27 (Mar 24) to 0.26, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.28 (Mar 24) to 0.30, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.48. It has decreased from 0.55 (Mar 24) to 0.48, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 1.76 (Mar 24) to 1.59, marking a decrease of 0.17.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.48 (Mar 24) to 1.33, marking a decrease of 0.15.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.95. This value is below the healthy minimum of 4. It has decreased from 4.13 (Mar 24) to 3.95, marking a decrease of 0.18.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 24.74. This value is within the healthy range. It has increased from 20.46 (Mar 24) to 24.74, marking an increase of 4.28.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.39. This value is below the healthy minimum of 20. It has increased from 7.27 (Mar 24) to 8.39, marking an increase of 1.12.
- For Earning Retention Ratio (%), as of Mar 25, the value is 75.26. This value exceeds the healthy maximum of 70. It has decreased from 79.54 (Mar 24) to 75.26, marking a decrease of 4.28.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.61. This value exceeds the healthy maximum of 70. It has decreased from 92.73 (Mar 24) to 91.61, marking a decrease of 1.12.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.67. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 6.67, marking a decrease of 0.98.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.04. This value is within the healthy range. It has decreased from 3.21 (Mar 24) to 3.04, marking a decrease of 0.17.
- For Enterprise Value (Cr.), as of Mar 25, the value is 39,795.55. It has decreased from 41,059.80 (Mar 24) to 39,795.55, marking a decrease of 1,264.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 2.85, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 14.96. This value is within the healthy range. It has increased from 13.90 (Mar 24) to 14.96, marking an increase of 1.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 2.51 (Mar 24) to 2.47, marking a decrease of 0.04.
- For Retention Ratios (%), as of Mar 25, the value is 75.25. This value exceeds the healthy maximum of 70. It has decreased from 79.53 (Mar 24) to 75.25, marking a decrease of 4.28.
- For Price / BV (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has decreased from 2.25 (Mar 24) to 1.99, marking a decrease of 0.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 2.51 (Mar 24) to 2.47, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dalmia Bharat Ltd:
- Net Profit Margin: 5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.31% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.93% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.04
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 35.1 (Industry average Stock P/E: 42.12)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.3
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Dalmiapuram, Lalgudi, Tiruchirapalli Dist. Tamil Nadu 621651 | investorrelations@dalmiabharat.com https://www.dalmiabharat.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yadu Hari Dalmia | Chairman & Non-Exe.Director |
| Mr. Gautam Dalmia | Managing Director |
| Mr. Puneet Yadu Dalmia | Managing Director & CEO |
| Dr. Niddodi Subrao Rajan | Non Executive Director |
| Mrs. Anuradha Mookerjee | Ind. Non-Executive Director |
| Mr. Paul Heinz Hugentobler | Ind. Non-Executive Director |
| Mr. Haigreve Khaitan | Ind. Non-Executive Director |
| Mr. Anuj Gulati | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Dalmia Bharat Ltd?
Dalmia Bharat Ltd's intrinsic value (as of 03 November 2025) is 1083.73 which is 47.95% lower the current market price of 2,082.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 39,058 Cr. market cap, FY2025-2026 high/low of 2,496/1,601, reserves of ₹17,336 Cr, and liabilities of 30,171 Cr.
What is the Market Cap of Dalmia Bharat Ltd?
The Market Cap of Dalmia Bharat Ltd is 39,058 Cr..
What is the current Stock Price of Dalmia Bharat Ltd as on 03 November 2025?
The current stock price of Dalmia Bharat Ltd as on 03 November 2025 is 2,082.
What is the High / Low of Dalmia Bharat Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dalmia Bharat Ltd stocks is 2,496/1,601.
What is the Stock P/E of Dalmia Bharat Ltd?
The Stock P/E of Dalmia Bharat Ltd is 35.1.
What is the Book Value of Dalmia Bharat Ltd?
The Book Value of Dalmia Bharat Ltd is 926.
What is the Dividend Yield of Dalmia Bharat Ltd?
The Dividend Yield of Dalmia Bharat Ltd is 0.43 %.
What is the ROCE of Dalmia Bharat Ltd?
The ROCE of Dalmia Bharat Ltd is 5.58 %.
What is the ROE of Dalmia Bharat Ltd?
The ROE of Dalmia Bharat Ltd is 4.15 %.
What is the Face Value of Dalmia Bharat Ltd?
The Face Value of Dalmia Bharat Ltd is 2.00.